WO2005087920A3 - Recombinant chondroitinase abc i and uses thereof - Google Patents
Recombinant chondroitinase abc i and uses thereof Download PDFInfo
- Publication number
- WO2005087920A3 WO2005087920A3 PCT/US2005/008194 US2005008194W WO2005087920A3 WO 2005087920 A3 WO2005087920 A3 WO 2005087920A3 US 2005008194 W US2005008194 W US 2005008194W WO 2005087920 A3 WO2005087920 A3 WO 2005087920A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chondroitinase abc
- treating
- gags
- enzymes
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05735137A EP1737954A2 (en) | 2004-03-10 | 2005-03-10 | Recombinant chondroitinase abc i and uses thereof |
CA002558984A CA2558984A1 (en) | 2004-03-10 | 2005-03-10 | Recombinant chondroitinase abc i and uses thereof |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55223204P | 2004-03-10 | 2004-03-10 | |
US60/552,232 | 2004-03-10 | ||
US57891704P | 2004-06-10 | 2004-06-10 | |
US60/578,917 | 2004-06-10 | ||
US62505204P | 2004-11-03 | 2004-11-03 | |
US60/625,052 | 2004-11-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005087920A2 WO2005087920A2 (en) | 2005-09-22 |
WO2005087920A3 true WO2005087920A3 (en) | 2006-02-02 |
Family
ID=34965511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/008194 WO2005087920A2 (en) | 2004-03-10 | 2005-03-10 | Recombinant chondroitinase abc i and uses thereof |
Country Status (4)
Country | Link |
---|---|
US (5) | US7507570B2 (en) |
EP (1) | EP1737954A2 (en) |
CA (1) | CA2558984A1 (en) |
WO (1) | WO2005087920A2 (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000012726A2 (en) * | 1998-08-27 | 2000-03-09 | Massachusetts Institute Of Technology | Rationally designed heparinases derived from heparinase i and ii |
EP1190364A2 (en) * | 1999-04-23 | 2002-03-27 | Massachusetts Institute Of Technology | System and method for polymer notation |
EP1266013B1 (en) * | 2000-03-08 | 2014-10-15 | Massachusetts Institute Of Technology | Heparinase iii and uses thereof |
WO2002023190A2 (en) | 2000-09-12 | 2002-03-21 | Massachusetts Institute Of Technology | Methods and products related to low molecular weight heparin |
CA2423469A1 (en) | 2000-10-18 | 2002-04-25 | Massachusetts Institute Of Technology | Methods and products related to pulmonary delivery of polysaccharides |
JP4416664B2 (en) | 2002-05-03 | 2010-02-17 | マサチューセッツ・インスティテュート・オブ・テクノロジー | Δ4,5 glycuronidase and use thereof |
EP1575548B1 (en) | 2002-05-04 | 2011-03-09 | Acorda Therapeutics, Inc. | Compositions and methods for promoting neuronal outgrowth |
JP4657726B2 (en) | 2002-05-20 | 2011-03-23 | マサチューセッツ インスティテュート オブ テクノロジー | A novel method for sequencing using NMR |
AU2003265561A1 (en) * | 2002-08-15 | 2004-03-03 | Acorda Therapeutics, Inc. | Chimeric protein |
JP4606712B2 (en) * | 2003-01-08 | 2011-01-05 | マサチューセッツ インスティテュート オブ テクノロジー | 2-O sulfatase compositions and related methods |
MXPA05012305A (en) * | 2003-05-16 | 2006-04-18 | Acorda Therapeutics Inc | Compositions and methods for the treatment of cns injuries. |
MXPA05012307A (en) * | 2003-05-16 | 2006-07-03 | Acorda Therapeutics Inc | Proteoglycan degrading mutants for treatment of cns. |
US7959914B2 (en) * | 2003-05-16 | 2011-06-14 | Acorda Therapeutics, Inc. | Methods of reducing extravasation of inflammatory cells |
WO2005087920A2 (en) | 2004-03-10 | 2005-09-22 | Massachusetts Institute Of Technology | Recombinant chondroitinase abc i and uses thereof |
US20060127950A1 (en) | 2004-04-15 | 2006-06-15 | Massachusetts Institute Of Technology | Methods and products related to the improved analysis of carbohydrates |
WO2005111627A2 (en) | 2004-04-15 | 2005-11-24 | Massachusetts Institute Of Technology | Methods and products related to the improved analysis of carbohydrates |
AU2005244933B2 (en) * | 2004-05-18 | 2011-08-04 | Acorda Therapeutics, Inc. | Methods of purifying chondroitinase and stable formulations thereof |
US8765122B2 (en) * | 2004-06-14 | 2014-07-01 | The Research Foundation Of State University Of New York | Nanosphere/microsphere delivery system for the treatment of spinal cord injury |
CA2614068A1 (en) | 2004-06-29 | 2006-08-24 | Massachusetts Institute Of Technology | Methods and compositions related to the modulation of intercellular junctions |
US20060154894A1 (en) * | 2004-09-15 | 2006-07-13 | Massachusetts Institute Of Technology | Biologically active surfaces and methods of their use |
EP1928490B8 (en) * | 2005-09-26 | 2012-10-03 | Acorda Therapeutics, Inc. | Compositions and methods of using chondroitinase abci mutants |
EP2008096A2 (en) * | 2006-04-03 | 2008-12-31 | Massachusetts Institute of Technology | Glycomic patterns for the detection of disease |
US20090196858A1 (en) * | 2006-05-19 | 2009-08-06 | Aichi Prefecture | Ameliorating agent for brain damage |
AU2014200000B2 (en) * | 2006-10-10 | 2016-04-21 | Acorda Therapeutics, Inc. | Compositions and methods of using chondroitinase abci mutants |
US7722864B2 (en) | 2006-10-10 | 2010-05-25 | Acorda Therapeutics, Inc. | Compositions and methods of using chondroitinase ABCI mutants |
AU2016206267B2 (en) * | 2006-10-10 | 2018-07-05 | Acorda Therapeutics, Inc. | Compositions and methods of using chondroitinase abci mutants |
WO2008085912A1 (en) * | 2007-01-05 | 2008-07-17 | Massachusetts Institute Of Technology | Compositions of and methods of using sulfatases from flavobacterium heparinum |
GB0712302D0 (en) * | 2007-06-22 | 2007-08-01 | Cambridge Entpr Ltd | Chrondroitinase polypeptides |
US8450106B2 (en) * | 2007-10-17 | 2013-05-28 | The Ohio State University Research Foundation | Oncolytic virus |
US20090286289A1 (en) * | 2008-03-10 | 2009-11-19 | Pang Danny Z | Production of Hyaluronate Unsaturated Disaccharides and its Application |
US20140212404A1 (en) * | 2012-11-14 | 2014-07-31 | Khizer Khaderi | Compositions and Methods for Treating Injuries to the Visual System of a Human |
WO2014201220A1 (en) * | 2013-06-12 | 2014-12-18 | The Board Of Trustees Of The University Of Illinois | Methods for detecting prostate cancer |
US9896488B2 (en) | 2013-06-18 | 2018-02-20 | University Of Helsinki | Protamine in treatment of neuronal injuries |
US20160244740A1 (en) * | 2013-09-27 | 2016-08-25 | Ohio State Innovation Foundation | Mutant chondroitinase abc i compositions and methods of their use |
KR102167443B1 (en) * | 2019-03-25 | 2020-10-19 | 주식회사 카티프라임 | In vitro osteoarthritis condition model and drug screening method for osteoarthritis using the same |
CN111593040B (en) * | 2020-06-20 | 2022-08-30 | 山东大学 | Dermatan sulfate lyase and application thereof |
CN116042593B (en) * | 2023-01-16 | 2023-07-14 | 山东省农业科学院畜牧兽医研究所 | Clostridium perfringens bacteriophage lyase and application thereof in preparation of clostridium perfringens infection resistant medicines |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0613949A2 (en) * | 1993-02-24 | 1994-09-07 | Maruha Corporation | Gene encoding chondroitinase ABC and uses therefor |
WO2003102160A2 (en) * | 2002-06-03 | 2003-12-11 | Massachusetts Institute Of Technology | Rationally designed polysaccharide lyases derived from chondroitinase b |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US739904A (en) * | 1902-08-05 | 1903-09-29 | Orville Mcnorton Jr | Music holder and turner. |
ZA912770B (en) * | 1990-04-16 | 1992-01-29 | Bethesda Eye Inst | Enzymatic disinsertion of vitreous body |
JPH04270327A (en) | 1991-02-26 | 1992-09-25 | Fuji Photo Optical Co Ltd | Exposure correcting device for camera |
US6001630A (en) * | 1992-06-26 | 1999-12-14 | Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) | Pharmaceutical compositions of chondroitinase ABC isolated from Proteus vulgaris ATCC 6896 |
US5496718A (en) * | 1992-06-26 | 1996-03-05 | Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) | Chondroitinase ABC isolated from proteus vulgaris ATCC 6896 |
US5773277A (en) * | 1992-06-26 | 1998-06-30 | Seikagaku Kogyo Kabushiki Kaisha | Crystalline chondroitinase isolated from Proteus vulgaris ATCC 6896 |
JPH09500011A (en) | 1993-04-23 | 1997-01-07 | アメリカン サイアナミド カンパニー | P. Cloning and expression of chondroitinase I and II genes from Bulgaris |
US5578480A (en) * | 1993-04-23 | 1996-11-26 | American Cyanamid Company | Methods for the isolation and purification of the recombinantly expressed chondroitinase I and II enzymes from P. vulgaris |
US5525500A (en) * | 1994-04-22 | 1996-06-11 | American Cyanamid Company | Chromatographic process for the copurification of chondroitinase I and II proteins from Proteus vulgaris |
US5498536A (en) * | 1994-04-22 | 1996-03-12 | American Cyanamid Company | Chondroitinase II from Proteus vulgaris |
AU2428195A (en) * | 1994-04-22 | 1995-11-16 | American Cyanamid Company | Chondroitinases i and ii, methods of preparation, and use thereof |
US6093563A (en) * | 1994-07-08 | 2000-07-25 | Ibex Technologies R And D, Inc. | Chondroitin lyase enzymes |
US5997863A (en) * | 1994-07-08 | 1999-12-07 | Ibex Technologies R And D, Inc. | Attenuation of wound healing processes |
US5888798A (en) * | 1995-06-07 | 1999-03-30 | American Cyanamid Company | Chondroitinase I and chondroitinase II producing mutants of P. vulgaris |
US6217863B1 (en) * | 1995-10-30 | 2001-04-17 | Massachusetts Institute Of Technology | Rationally designed polysaccharide lyases derived from heparinase I |
EP0875253B1 (en) * | 1997-05-02 | 2005-04-06 | Seikagaku Corporation | Chondroitinase compositions |
JP2000044601A (en) | 1998-07-29 | 2000-02-15 | Seikagaku Kogyo Co Ltd | New galactosaminoglucan |
WO2000012726A2 (en) | 1998-08-27 | 2000-03-09 | Massachusetts Institute Of Technology | Rationally designed heparinases derived from heparinase i and ii |
US7056504B1 (en) * | 1998-08-27 | 2006-06-06 | Massachusetts Institute Of Technology | Rationally designed heparinases derived from heparinase I and II |
EP1190364A2 (en) * | 1999-04-23 | 2002-03-27 | Massachusetts Institute Of Technology | System and method for polymer notation |
ATE413886T1 (en) | 1999-11-17 | 2008-11-15 | Biomarin Pharm Inc | REDUCING ANGIOGENESIS USING CHONDROITIN SULPHATE DEGRADING ENZYMES |
EP1266013B1 (en) * | 2000-03-08 | 2014-10-15 | Massachusetts Institute Of Technology | Heparinase iii and uses thereof |
US7094165B2 (en) * | 2000-03-17 | 2006-08-22 | Delbert Clarke Pile | Apparatus and method for a retractable basketball backboard and hoop assembly |
WO2002023190A2 (en) * | 2000-09-12 | 2002-03-21 | Massachusetts Institute Of Technology | Methods and products related to low molecular weight heparin |
CA2423469A1 (en) * | 2000-10-18 | 2002-04-25 | Massachusetts Institute Of Technology | Methods and products related to pulmonary delivery of polysaccharides |
AU2002306921A1 (en) * | 2001-03-27 | 2002-10-08 | Massachusetts Institute Of Technology | Methods and products related to fgf dimerization |
GB0205022D0 (en) * | 2002-03-04 | 2002-04-17 | Univ Cambridge Tech | Materials and methods for the treatment of cns damage |
JP4416664B2 (en) * | 2002-05-03 | 2010-02-17 | マサチューセッツ・インスティテュート・オブ・テクノロジー | Δ4,5 glycuronidase and use thereof |
JP4657726B2 (en) * | 2002-05-20 | 2011-03-23 | マサチューセッツ インスティテュート オブ テクノロジー | A novel method for sequencing using NMR |
JP4606712B2 (en) | 2003-01-08 | 2011-01-05 | マサチューセッツ インスティテュート オブ テクノロジー | 2-O sulfatase compositions and related methods |
MXPA05012307A (en) | 2003-05-16 | 2006-07-03 | Acorda Therapeutics Inc | Proteoglycan degrading mutants for treatment of cns. |
WO2005087920A2 (en) | 2004-03-10 | 2005-09-22 | Massachusetts Institute Of Technology | Recombinant chondroitinase abc i and uses thereof |
WO2005110438A2 (en) | 2004-04-15 | 2005-11-24 | Massachusetts Institute Of Technology | Methods and products related to the intracellular delivery of polysaccharides |
WO2005111627A2 (en) | 2004-04-15 | 2005-11-24 | Massachusetts Institute Of Technology | Methods and products related to the improved analysis of carbohydrates |
US20060127950A1 (en) * | 2004-04-15 | 2006-06-15 | Massachusetts Institute Of Technology | Methods and products related to the improved analysis of carbohydrates |
CA2614068A1 (en) | 2004-06-29 | 2006-08-24 | Massachusetts Institute Of Technology | Methods and compositions related to the modulation of intercellular junctions |
US20060154894A1 (en) * | 2004-09-15 | 2006-07-13 | Massachusetts Institute Of Technology | Biologically active surfaces and methods of their use |
US20070020243A1 (en) * | 2005-01-12 | 2007-01-25 | Massachusetts Institute Of Technology | Methods and compositions related to modulating the extracellular stem cell environment |
WO2006105315A2 (en) | 2005-03-29 | 2006-10-05 | Massachusetts Institute Of Technology | Compositions and methods for regulating inflammatory responses |
WO2006105313A2 (en) | 2005-03-29 | 2006-10-05 | Massachusetts Institute Of Technology | Compositions of and methods of using oversulfated glycosaminoglycans |
US7429373B2 (en) * | 2005-06-24 | 2008-09-30 | Air Products And Chemicals, Inc. | Process for autothermal generation of hydrogen |
EP2008096A2 (en) | 2006-04-03 | 2008-12-31 | Massachusetts Institute of Technology | Glycomic patterns for the detection of disease |
WO2008085912A1 (en) * | 2007-01-05 | 2008-07-17 | Massachusetts Institute Of Technology | Compositions of and methods of using sulfatases from flavobacterium heparinum |
-
2005
- 2005-03-10 WO PCT/US2005/008194 patent/WO2005087920A2/en active Application Filing
- 2005-03-10 CA CA002558984A patent/CA2558984A1/en not_active Abandoned
- 2005-03-10 EP EP05735137A patent/EP1737954A2/en not_active Withdrawn
- 2005-03-10 US US11/078,915 patent/US7507570B2/en active Active
-
2006
- 2006-12-13 US US11/638,318 patent/US8338119B2/en active Active
- 2006-12-13 US US11/638,094 patent/US7592152B2/en not_active Expired - Fee Related
- 2006-12-13 US US11/638,287 patent/US7662604B2/en not_active Expired - Fee Related
- 2006-12-13 US US11/638,178 patent/US7553950B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0613949A2 (en) * | 1993-02-24 | 1994-09-07 | Maruha Corporation | Gene encoding chondroitinase ABC and uses therefor |
WO2003102160A2 (en) * | 2002-06-03 | 2003-12-11 | Massachusetts Institute Of Technology | Rationally designed polysaccharide lyases derived from chondroitinase b |
Non-Patent Citations (2)
Title |
---|
BRADBURY E J ET AL: "Chondroitinase ABC promotes regeneration and functional recovery following spinal cord injury", SOCIETY FOR NEUROSCIENCE ABSTRACTS, SOCIETY FOR NEUROSCIENCE, US, vol. 27, no. part 2, 2001, pages 1835, XP002244997, ISSN: 0190-5295 * |
DENHOLM E M ET AL: "ANTI-TUMOR ACTIVITIES OF CHONDROITINASE AC AND CHONDROITINASE B: INHIBITION OF ANGIOGENESIS, PROLIFERATION AND INVASION", EUROPEAN JOURNAL OF PHARMACOLOGY, AMSTERDAM, NL, vol. 416, no. 3, 2001, pages 213 - 221, XP001002664, ISSN: 0014-2999 * |
Also Published As
Publication number | Publication date |
---|---|
CA2558984A1 (en) | 2005-09-22 |
US20070148157A1 (en) | 2007-06-28 |
US20060078959A1 (en) | 2006-04-13 |
US7592152B2 (en) | 2009-09-22 |
US7553950B2 (en) | 2009-06-30 |
US8338119B2 (en) | 2012-12-25 |
US20070148740A1 (en) | 2007-06-28 |
US20070202563A1 (en) | 2007-08-30 |
WO2005087920A2 (en) | 2005-09-22 |
EP1737954A2 (en) | 2007-01-03 |
US7662604B2 (en) | 2010-02-16 |
US20070224670A1 (en) | 2007-09-27 |
US7507570B2 (en) | 2009-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005087920A3 (en) | Recombinant chondroitinase abc i and uses thereof | |
Fallacara et al. | Hyaluronic acid in the third millennium | |
WO2007084769A3 (en) | Microalgae-derived compositions for improving the health and appearance of skin | |
WO2003102160A3 (en) | Rationally designed polysaccharide lyases derived from chondroitinase b | |
WO2006071802A3 (en) | Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells | |
US20080274999A1 (en) | Hyaluronic Acid Fraction with Moisturizing and Anti-Wrinkle Properties | |
WO2003078960A3 (en) | Analysis of sulfated polysaccharides | |
WO2006032500A3 (en) | Immunogenic composition | |
WO2011056688A3 (en) | Molecular profiling for personalized medicine | |
WO2008005303A3 (en) | Thiazolopyrimidine modulators of trpv1 | |
WO2007140231A3 (en) | Low molecular weight heparin composition and uses thereof | |
WO2004062592A3 (en) | 2-o sulfatase compositions and related methods | |
EA200801717A1 (en) | LOCAL APPLICATION COMPOSITION FOR SKIN CARE, PRODUCT ON ITS BASIS AND METHOD OF TREATMENT | |
ITPD20050206A1 (en) | BIOMATERIALS IN THE FORM OF FIBER TO BE USED AS MEDICAL DEVICES IN THE TREATMENT OF WOUNDS AND THEIR PROCESSES OF PRODUCTION | |
HK1118011A1 (en) | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation, and their use in the pharmaceutical field | |
US8071757B2 (en) | Aryl/alkyl vinyl sulfone hyaluronic acid derivatives | |
ATE488548T1 (en) | METHOD FOR PRODUCING GLUCOMANN ANGLE PARTICLES | |
MX2008002164A (en) | Method for producing cellulose ether products with increased viscosity and fineness. | |
RU2017124620A (en) | Vaccination of Cyclodextrin with Amide Bonds to Hyaluronic Acid Cross-Linked with Ether and Their Use | |
US20220304355A1 (en) | Identification and selection of a plant starting material of a plant chondroitin sulfate and hyaluronic acid, and transformation of such plant starting material to obtain ingredients for use in foods, supplements, medical devices or drugs | |
WO2009102880A3 (en) | Structure and bioactivity of the polysaccharides and oligomers in medicinal plant dendrobium huoshanense | |
IL172477A0 (en) | Viscosupplementation with algal polysaccharides in the treatment of arthritis | |
DK2794665T3 (en) | NON-ANTICOAGULATIVE GLYCOSAMINOGLYCANES COMPREHENSIVE DISACCHARID REPEATING UNIT AND MEDICAL USE THEREOF | |
WO2007149554A3 (en) | Methods for restoring neural function | |
SI2794667T1 (en) | Low anticoagulant heparins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2558984 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005735137 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2005735137 Country of ref document: EP |